← FDA Drug Approvals (Drugs@FDA)

ACETYLCYSTEINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SAGENT PHARMS INC · Approved 2017-10-31

Drug application

FDA Application #

ANDA091684

Application type

Abbreviated New Drug Application (Generic)

Brand name

ACETYLCYSTEINE

Generic name

ACETYLCYSTEINE

Active ingredients

ACETYLCYSTEINE

Dosage form

INJECTABLE

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

SAGENT PHARMS INC

Manufacturer

Sagent Pharmaceuticals

First approval

2017-10-31

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown